87 results
Page 3 of 5
8-K
EX-99.2
qj80qnfmanpl2 io
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
8-K
EX-1.1
ttk nm92solhn39o9r
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
424B5
jmorufmbhpd1hv
7 Jan 21
Prospectus supplement for primary offering
4:16pm
424B5
ismxe1j1lgfm3r
6 Jan 21
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
uffrx0zryqwz
4 Jan 21
T Cell Engager for Treatment of Small Cell Lung Cancer and other
4:00pm
8-K
EX-99.1
wy8p2 d863
11 Dec 20
Other Events
5:06pm
8-K
EX-99.1
qkhc2j
9 Dec 20
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTACĀ® Pipeline Development Programs
4:52pm
8-K
EX-99.2
8bobf6ad4m6 j3s865ru
9 Dec 20
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTACĀ® Pipeline Development Programs
4:52pm
8-K
EX-99.1
9yt4hzq 0hzi
4 Nov 20
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
kypg utvz5t4
5 Aug 20
Harpoon Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:12pm
8-K
EX-99.2
bra4j9kkxchz5t
29 May 20
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose
4:03pm
8-K
EX-99.1
j4knz 0xn
29 May 20
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose
4:03pm
8-K
EX-99.1
st13yb0p
6 May 20
Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:10pm
DEF 14A
zva4v8a2aoywwke6ik4
17 Apr 20
Definitive proxy
5:02pm
S-3
EX-1.1
97v1hfd
13 Mar 20
Shelf registration
4:53pm
8-K
EX-99.1
rthpyad7
12 Mar 20
Harpoon Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update
4:11pm